Status
Conditions
Study type
Funder types
Identifiers
About
This study is to identify potential biomarkers for the early detection of Barrett's Esophagus, esophageal carcinoma (both adenocarcinoma and squamous cell carcinoma), and gastric cancer via sponge cytology.
Full description
This study is to identify potential biomarkers for the early detection of Barrett's Esophagus, esophageal carcinoma (both adenocarcinoma and squamous cell carcinoma). Esophageal and gastric cytology will be collected via sponge capsule. Candidate genes will be tested with DNA isolated from these samples in order to identify optimal biomarkers to differentiate between Barrett's esophagus and esophageal/gastric cancer versus normal esophageal/gastric tissue.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
2,500 participants in 4 patient groups
Loading...
Central trial contact
Stephen J Meltzer, M.D.
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal